Home Overview Press Room Blog Publications For Students about us
Search

About Global Governance & Human Biotechnology


Several important international bodies have adopted human biotechnology policies, though most regulation takes place at the national level.

International organizations have taken strong stands to prevent human reproductive cloning and inheritable genetic modification. The Council of Europe's Convention on Human Rights and Biomedicine (1997)óthe most authoritative international agreement to dateóbans inheritable genetic modification, human reproductive cloning, and research cloning while also regulating other human biotechnologies.

UNESCO, the European Parliament, the Group of Eight industrial nations, the World Health Assembly, and the United Nations have also adopted various prohibitions on human reproductive cloning.



If We Create Life, Who Will Control It?by Marcelo GleiserNPRSeptember 17th, 2014It is the world of the future, and we must have some control over where it's going. But how?
On the Irreversibility of Gene Drivesby Noam PrywesThe ScientistSeptember 16th, 2014Should researchers genetically modify wild populations of mosquitoes to curb vector-borne diseases like malaria?
International Surrogacy, Global Consumerism, Harms to Women and Childrenby Carmel Shalev, Biopolitical Times guest contributorSeptember 15th, 2014Medical associations, nations, and the international community must intervene in the unregulated global market for surrogacy to protect, promote and sanction the human dignity and human rights of women and children.
An International Agreement on Commercial Surrogacy? by Marcy DarnovskyBiopolitical TimesSeptember 4th, 2014A three-day convening in The Hague brought together scholars, womenís health and human rights advocates, and policymakers from 27 countries to tackle concerns about international commercial surrogacy.
Thailandís Business in Paid Surrogates May Be Foundering in a Moral Quagmireby Thomas FrankThe New York TimesAugust 26th, 2014The baby boomlet in Pak Ok was just one of several bizarre and often ethically charged iterations of Thailandís freewheeling venture into what detractors call the womb rental business, an unguided experiment that the countryís military government now says it is planning to end.
Biologists Choose Sides In Safety Debate Over Lab-Made Pathogensby Nell GreenfieldBoyceNPRAugust 13th, 2014A smoldering debate about whether researchers should ever deliberately create superflu strains and other risky germs in the interest of science has flared once again.
Thailand to Ban Commercial Surrogacy in Wake of Gammy ScandalThe GuardianAugust 13th, 2014Thailand's military government gave preliminary approval for a draft law to make commercial surrogacy a criminal offence.
Should We Open the Door to Genetically Modified Babies?by Jessica CussinsCNBCAugust 11th, 2014There has been a lot of confusion around this controversial issue, but as we are now facing a historic crossroads, it is important to set the record straight.
CGS to Chair Sessions at Forum on Cross-Border Surrogacy and Adoption in The HagueAugust 11-13, 2014Nearly 100 scholars, acdvocates, and policymakers from 27 countries will come together at the International Forum on Intercountry Adoption and Global Surrogacy.
Failures and Risks in Biosafety Regulationby Pete ShanksBiopolitical TimesJuly 24th, 2014Accidents at CDC and elsewhere point up the difficulties in regulating potentially dangerous releases of genetically modified organisms, which scientists are, quite responsibly, discussing.
Displaying 1-10 of 215  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760